HEALTH● LOWAug 18 · Aug 18, 2026, 3:03 PM
NRx targets 2026 KETAFREE approval and outlines SPARC-TMS trial in 400 patients backed by military funding
Seeking Alpha Tech
NRx aims for KETAFREE approval by 2026 and has outlined a SPARC-TMS trial involving 400 patients. This medical research is supported by military funding.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoOver 65s expensive target in health insurance debatemandurahmail.com.au · AustraliaHEALTH1h agoDitch the mat and try standing crunches for a stronger , more balanced coregq.co.za · South AfricaHEALTH1h agoUnending three-times-a-week dialysis, relied-upon overseas transplant 'failed' - a woman's regretsAsahi ShimbunHEALTH1h agoNew Zealand approves party-drug MDMA for treating patients with PTSDEuroNews [en]